Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells

被引:0
|
作者
Oktávia Tarjányi
Julian Haerer
Mónika Vecsernyés
Gergely Berta
Alexandra Stayer-Harci
Bálint Balogh
Kornélia Farkas
Ferenc Boldizsár
József Szeberényi
György Sétáló
机构
[1] University of Pécs,Department of Medical Biology and Central Electron Microscope Laboratory
[2] Medical School,Signal Transduction Research Group
[3] János Szentágothai Research Centre,Institute of Bioanalysis
[4] University of Pécs,Department of Immunology and Biotechnology
[5] Medical School,undefined
[6] University of Pécs,undefined
[7] Medical School,undefined
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Rat pheochromocytoma (PC12) cells were treated with the proteasome inhibitor MG-132 and morphological changes were recorded. Initially, neuronal differentiation was induced but after 24 h signs of morphological deterioration became apparent. We performed nuclear staining, flow cytometry and WST-1 assay then analyzed signal transduction pathways involving Akt, p38 MAPK (Mitogen-Activated Protein Kinase), JNK (c-Jun N-terminal Kinase), c-Jun and caspase-3. Stress signaling via p38, JNK and c-Jun was active even after 24 h of MG-132 treatment, while the survival-mediating Akt phosphorylation declined and the executor of apoptosis (caspase-3) was activated by that time and apoptosis was also observable. We examined subcellular localization of stress signaling components, applied kinase inhibitors and dominant negative H-Ras mutant-expressing PC12 cells in order to decipher connections of stress-mediating pathways. Our results are suggestive of that treatment with the proteasome inhibitor MG-132 has a biphasic nature in PC12 cells. Initially, it induces neuronal differentiation but prolonged treatments lead to apoptosis.
引用
收藏
相关论文
共 50 条
  • [21] Nardostachys chinensis glycoside induces characteristics of neuronal differentiation in rat pheochromocytoma PC12 cells
    Liu, JH
    Yin, F
    Zheng, XX
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (04) : 768 - 771
  • [22] Effect of Urotensin II on PC12 Rat Pheochromocytoma Cells
    Aita, Y.
    Kasahara, T.
    Isobe, K.
    Kawakami, Y.
    Takekoshi, K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2010, 22 (02) : 83 - 91
  • [23] ARE UNDIFFERENTIATED PC12 RAT PHEOCHROMOCYTOMA CELLS ELECTRICALLY EXCITABLE
    JANIGRO, D
    MACCAFERRI, G
    MELDOLESI, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (02) : 810 - 814
  • [24] CDK4, a possible critical regulator of apoptosis in rat pheochromocytoma PC12 cells
    Dobashi, Y
    Shoji, M
    Kondo, E
    Akiyama, T
    Kameya, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (03) : 609 - 613
  • [25] Melatonin reduces amyloid β-induced apoptosis in pheochromocytoma (PC12) cells
    Feng, Z
    Zhang, JT
    JOURNAL OF PINEAL RESEARCH, 2004, 37 (04) : 257 - 266
  • [26] Influence of proteasome inhibitor MG-132 on the expression of Hsp70 and myocardial apoptosis after myocardial infarction
    Wu, Xin-Hua
    Chen, Zhang-Rong
    Yang, Wei
    Yang, Ying
    Dong, Yu
    Liu, Hong
    Kuang, Shi-Quan
    Luo, Kai-Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3569 - 3577
  • [27] Proteasome Inhibitor MG132 Induces Apoptosis and Inhibits Invasion of Human Malignant Pleural Mesothelioma Cells
    Yuan, Bao-Zhu
    Chapman, Joshua A.
    Reynolds, Steven H.
    TRANSLATIONAL ONCOLOGY, 2008, 1 (03): : 129 - 140
  • [28] Proteasome inhibitor MG132 induces apoptosis in human osteosarcoma U2OS cells
    Lee, Han Ki
    Park, See-Hyoung
    Nam, Myeong Jin
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (11) : 1985 - 1997
  • [29] KATP channel block prevents proteasome inhibitor-induced apoptosis in differentiated PC12 cells
    Nam, Yoon Jeong
    Lee, Da Hee
    Lee, Min Sung
    Lee, Chung Soo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 : 582 - 591
  • [30] The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
    Pajonk, F
    van Ophoven, A
    Weissenberger, C
    McBride, WH
    BMC CANCER, 2005, 5 (1)